Pharmaceutical

Lawsuits mount against Actos diabetes drug maker

If you have taken the type 2 diabetes drug Actos and were diagnosed with bladder cancer, you may have a case against the manufacturer. More and more lawsuits are being filed against Takeda Pharmaceuticals by people who claim the company knew the drug could cause cancer but intentionally hid it from the public.

Among the latest lawsuits to be filed are those by three couples in Illinois. The lawsuits say the men took Actos as part of their doctors’ plans to treat their type 2 diabetes. It wasn’t until years later the men allege they learned that the medication they were taking increased their chances of developing bladder cancer. The complaints cite numerous studies that document an increased risk of bladder cancer in patients who used the drug for more than 12 months. However, the men allege those studies were never released to the public or the data published. The lawsuits allege that Takeda purposefully withheld the information.

It wasn’t until the Food and Drug Administration (FDA) reviewed safety data on Actos in June 2011 that the agency issued a warning about bladder cancer with long-term use of Actos, and a warning was placed on the drug’s safety label. A month after the FDA issued its warning on Actos, the drug was recalled in France.

Actos makes up $4.8 billion – or nearly 27 percent – of Takeda’s revenue. The lawsuit filed by the three Illinois men and their wives accuse Takeda of being negligent for failing to improve the medication and reduce the risk posed to patients. The plaintiffs say they have endured pain and suffering, economic loss, and loss of consortium as a result of the defendant’s negligence. They are seeking compensation for their actual and punitive damages.

 

ACTOS is a trademark of Takeda Pharmaceutical Company Limited registered with the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc.

Source: Madison Record